Gupta, A., et al. Effects of Rhodiola imbricata
on dermal wound healing. Planta Med 73, no. 8 (2007): 774–77.Gupta, V., et al. Anti-oxidative effect of Rhodiola imbricata
root extract in rats during cold, hypoxia and restraint (C-H-R) exposure and post-stress recovery. Food Chem Toxicol 48, no. 4 (2010): 1019–25.Gupta, V., et al. A dose dependent adaptogenic and safety evaluation of Rhodiola imbricata
Edgew, a high altitude rhizome. Food Chem Toxicol 46, no. 5 (2008): 1645–52.Gupta, V., et al. Mechanism of action of Rhodiola imbricata
Edgew during exposure to cold, hypoxia and restraint (C-H-R) stress induced hypothermia and post stress recovery in rats. Food Chem Toxicol 47, no. 6 (2009): 1239–45.Ha, Z., et al. The effect of rhodiola and acetazolamide on the sleep architecture and blood oxygen saturation in men living at high altitude. Zhonghua Jie He He Hu Xi Za Zhi
25, no. 9 (2002): 527–30.Hellum, B. H., et al. Potent in vitro inhibition of CYP3A4 and P-glycoprotein by Rhodiola rosea. Planta Med
76, no. 4 (2010): 331–38.Huang, S. C., et al. Attenuation of long-term Rhodiola rosea
supplementation on exhaustive swimming-evoked oxidative stress in the rat. Chin J Physiol 52, no. 5 (2009): 316–24.Hung, S. K., et al. The effectiveness and efficacy of Rhodiola rosea
L.: a systematic review of randomized clinical trials. Phytomedicine 18, no. 4 (2011): 235–44. E-pub (preprint) October 30, 2010.Iaremiĭ, I. N., et al. Hepatoprotective properties of liquid extract of Rhodiola rosea. Eksp Klin Farmakol
65, no. 6 (2002): 57–59.Jafari, M., et al. Rhodiola
: a promising anti-aging Chinese herb. Rejuvenation Res 10, no. 4 (2007): 587–602.Jang, S. L. Salidroside from Rhodiola sachalinensis
protects neuronal PC12 cells against cytotoxicity induced by amyloid-beta. Immunopharmacol Immunotoxicol 25, no. 3 (2003): 295–304.Jeong, H. J., et al. Neuraminidase inhibitory activities of flavonoids isolated from Rhodiola rosea
roots and their in vitro anti-influenza viral activities. Bioorg Med Chem 17, no. 19 (2009): 6816–23.Kang, S., et al. Comparative study of the constituents from 10 Rhodiola
plants. Zhong Yao Cai 20, no. 12 (1997): 616–18.Kanupriya., et al. Cytoprotective and antioxidant activity of Rhodiola imbricata
against tert-butyl hydroperoxide induced oxidative injury in U-937 human macrophages. Mol Cell Biochem 275, no. 1–2 (2005): 1–6.Kelly, G. S. Rhodiola rosea
: a possible plant adaptogen. Altern Med Rev 6, no. 3 (2001): 293–302.Khanum, F., et al. Rhodiola rosea
: a versatile adaptogen. Inst Food Tech 4 (2005): 55–62.Kobayashi, K., et al. Constituents of Rhodiola rosea
showing inhibitory effect on lipase activity in mouse plasma and alimentary canal. Planta Med 74, no. 14 (2008): 1716–19.Kormosh, N., et al. Effect of a combination of extract from several plants on cell-mediated and humoral immunity of patients with advanced ovarian cancer. Phytother Res
20, no. 5 (2006): 424–25.Kucinskaite, A., et al. Evaluation of biologically active compounds in roots and rhizomes of Rhodiola rosea
L. cultivated in Lithuania. Medicina (Kaunas) 43, no. 6 (2007): 487–494, 2007.Kucinskaite, A., et al. Experimental analysis of therapeutic properties of Rhodiola rosea
L. and its possible application in medicine. Medicina (Kaunas) 40, no. 7 (2004): 614–19.Kwon, Y. I., et al. Evaluation of Rhodiola crenulata
and Rhodiola rosea for management of type II diabetes and hypertension. Asia Pac J Clin Nutr 15, no. 3 (2006): 425–32.Lee, F. T., et al. Chronic Rhodiola rosea
extract supplementation enforces exhaustive swimming tolerance. Am J Chin Med 37, no. 3 (2009): 557–72.Lee, M. W., et al. Antioxidative phenolic compounds from the roots of Rhodiola sachalinensis
A. Bor. Arch Pharm Res 23, no. 5 (2000): 455–58.Lei, Y., et al. Chemical composition of the essential oils of two Rhodiola
species from Tibet. Z Naturforsch C 58, no. 3–4 (2003): 161–64.Li, C., et al. Study on the extraction process for saldroside and p-tyrosol in Rhodiola crenulata. Zhong Yao Cai
29, no. 11 (2006): 1239–41.Li, H. B., et al. Salidroside stimulated glucose uptake in skeletal muscle cells by activating AMPactivated protein kinase. Eur J Pharmacol
588, no. 2–3 (2008): 165–69.